
Protagenic Therapeutics, Inc. – NASDAQ:PTIXW
Protagenic Therapeutics stock price today
Protagenic Therapeutics stock price monthly change
Protagenic Therapeutics stock price quarterly change
Protagenic Therapeutics stock price yearly change
Protagenic Therapeutics key metrics
Market Cap | 4.36M |
Enterprise value | 280.59K |
P/E | -0.02 |
EV/Sales | N/A |
EV/EBITDA | -0.05 |
Price/Sales | N/A |
Price/Book | 0.02 |
PEG ratio | N/A |
EPS | -1.37 |
Revenue | N/A |
EBITDA | -5.31M |
Income | -6.00M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeProtagenic Therapeutics stock price history
Protagenic Therapeutics stock forecast
Protagenic Therapeutics financial statements
Jun 2023 | 0 | -1.20M | |
---|---|---|---|
Sep 2023 | 0 | -1.39M | |
Dec 2023 | 3.2K | -1.67M | -52380.75% |
Mar 2024 | 0 | -1.72M |
Jun 2023 | 6919121 | 1.50M | 21.76% |
---|---|---|---|
Sep 2023 | 5432642 | 1.28M | 23.56% |
Dec 2023 | 4323369 | 655.25K | 15.16% |
Mar 2024 | 2578558 | 446.09K | 17.3% |
Jun 2023 | -1.53M | 1.61M | 0 |
---|---|---|---|
Sep 2023 | -655.76K | 590.72K | -10 |
Dec 2023 | -1.14M | 2.27M | 10 |
Mar 2024 | -1.65M | 1.20M | 0 |
Protagenic Therapeutics alternative data
Mar 2024 | 2 |
---|---|
Apr 2024 | 2 |
May 2024 | 1 |
Jun 2024 | 1 |
Jul 2024 | 1 |
Protagenic Therapeutics other data
Period | Buy | Sel |
---|---|---|
Jun 2021 | 17000 | 0 |
May 2022 | 31000 | 0 |
-
What's the price of Protagenic Therapeutics stock today?
One share of Protagenic Therapeutics stock can currently be purchased for approximately $0.05.
-
When is Protagenic Therapeutics's next earnings date?
Unfortunately, Protagenic Therapeutics's (PTIXW) next earnings date is currently unknown.
-
Does Protagenic Therapeutics pay dividends?
No, Protagenic Therapeutics does not pay dividends.
-
How much money does Protagenic Therapeutics make?
Protagenic Therapeutics has a market capitalization of 4.36M.
-
What is Protagenic Therapeutics's stock symbol?
Protagenic Therapeutics, Inc. is traded on the NASDAQ under the ticker symbol "PTIXW".
-
What is Protagenic Therapeutics's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Protagenic Therapeutics?
Shares of Protagenic Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Protagenic Therapeutics have?
As Jul 2024, Protagenic Therapeutics employs 1 workers, which is 50% less then previous quarter.
-
When Protagenic Therapeutics went public?
Protagenic Therapeutics, Inc. is publicly traded company for more then 4 years since IPO on 27 Apr 2021.
-
What is Protagenic Therapeutics's official website?
The official website for Protagenic Therapeutics is protagenic.com.
-
Where are Protagenic Therapeutics's headquarters?
Protagenic Therapeutics is headquartered at 149 Fifth Avenue, New York, NY.
-
How can i contact Protagenic Therapeutics?
Protagenic Therapeutics's mailing address is 149 Fifth Avenue, New York, NY and company can be reached via phone at +212 9948200.
Protagenic Therapeutics company profile:

Protagenic Therapeutics, Inc.
protagenic.comNASDAQ
1
Biotechnology
Healthcare
Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114 is a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company was founded in 2016 and is based in New York, New York.
New York, NY 10010
CIK: 0001022899
ISIN: US74365N1110
CUSIP: 74365N111